Biotech & Life SciencesConstructionManufacturingClimate & EnergyHealthcareEducationGovernment & CivicHardware & Semiconductors
Axon Partners Group is a venture capital firm that focuses on broad technology and innovation, including Digital, Life Sciences, Deep Tech, and Climate Tech, investing in founder-led companies from seed to growth stages. Their strategy involves direct equity investments, fund of funds, corporate venture capital, and special opportunities, with a geographic emphasis on Europe, Israel, the US, and Latin America.
They made 4 investments in the last 12 months. Their most common stage is series-a (50% of deals). Average disclosed round size is $33.3M (across 10 rounds with reported amounts).
Portfolio
10
Fund Size
$800M
Top Stage
Series A
Last 12 Mo
4
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| IISAAC antisismica | Series A | $14M | Mar 2026 |
 Aspen Neuroscience | Series C | $115M | Nov 2025 |
 Catalyxx | Seed | $3M | May 2025 |
 Novatron Fusion Group | Series A | $10.8M | Mar 2025 |
| JJolt Electrodes | Series A | $6M | Jun 2023 |
| IInnovamat | Series A | $21M | Apr 2023 |
 RapidSOS | Series C | $75M | Oct 2022 |
| OONI | Series B | $75M | Jan 2022 |
| Aspen Neuroscience | Seed | $6.5M | Dec 2019 |
| MMercadoni | Series A | $6.2M | Jun 2017 |
Top Co-Investors
ARCH Venture Partners3 shared
OrbiMed2 shared
Section 322 shared
Climentum Capital2 shared
Domain Associates1 shared
Alexandria Venture Investments1 shared
Reach Capital1 shared
Kibo1 shared
Bonsai1 shared
10x Capital1 shared
Casdin Capital1 shared
The Vertical Group1 shared
Oxford Science Enterprises1 shared
Ship2B1 shared
CDP Venture Capital1 shared
360 Capital1 shared
Ring1 shared
Industrifonden1 shared
Insight Partners1 shared
NightDragon1 shared
Last updated: 8 March 2026